IP Library Granted Patent US 11,390,855
Granted Patent B2
US 11,390,855 · App. 16/440,777 · Granted Jul 19, 2022

Synthesis of fucosylated compounds

Inventors: Eric Hüfner (Hennef, DE); Julia Parkot (Cologne, DE); Stefan Jennewein (Aachen, DE)
Assignee: Chr. Hansen HMO GmbH
C12N9/12A23L33/00C12N9/1051A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,390,855
App. No.
16/440,777
Granted
Jul 19, 2022
Kind
B2
Abstract

A method for making a genetically modified cell having the ability to produce fucosylated compounds comprising the steps of: transforming the cell to express a fucose kinase, transforming the cell to express a fucose-1-phosphate guanylyltransferase, transforming the cell to express a fucosyltransferase.

Claims (8)

1. A method for making a fucosyllactose the method comprises cultivating a genetically modified Escherichia coli having the ability to produce the fucosyllactose under suitable cultivation conditions in a medium comprising L-fucose and an acceptor substrate, wherein said acceptor substrate is lactose, and wherein the Escherichia coli has been transformed to express

i) a gene encoding a bacterial bifunctional fucose kinase/fucose-1-phosphate guanylyltransferase, wherein the bacterial bifunctional fucose kinase/fucose-1-phosphate guanylyltransferase gene is an fkp gene of Bacteroides fragilis , and

ii) a gene encoding a fucosyltransferase from Helicobacter,

wherein at least one gene encoding a protein that functions in the catabolic pathway for fucose, selected from the group consisting of a fucose-1-phosphate aldolase gene (fucA gene), a fucose isomerase gene and a fuculose kinase gene, is inactivated in the Escherichia coli.

2. The method of claim 1 , wherein the fucosyllactose is 2′-fucosyllactose, 3-fucosyllactose or lactodifucotetraose.

3. The method of claim 1 , wherein the fucA gene encoding fucose-1-phosphate aldolase is deleted.

4. The method of claim 1 , wherein the fucosyllactose is 2′-fucosyllactose and the fucosyltransferase is an alpha-1,2-fucosyltransferase encoded by the Helicobacter pylori NCTC364 fucT2 gene.

5. The method of claim 1 , the fucosyllactose is 3-fucosyllactose and the fucosyltransferase is an alpha-1,3-fucosyltransferase encoded by the Helicobacter pylori 26695 futA gene.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 4, 2025
From: CHR. HANSEN HMO GMBH
To: CHR. HANSEN A/S
Reel/Frame 070396/0299 →
CHANGE OF NAME Recorded Apr 23, 2024
From: JENNEWEIN BIOTECHNOLOGIE GMBH
To: CHR. HANSEN HMO GMBH
Reel/Frame 067189/0392 →
Priority Claims (1)
EP 08172267 · Dec 19, 2008 · regional
Continuity (2)
Division 13140548
Related Publication 20190382737A1 · Dec 19, 2019